APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study (Q29416986)

16 April 2017

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study (English)

1 reference

genome-wide association study

16 April 2017

0 references

author

Alzheimer's Disease Neuroimaging Initiative

18

object named as

Alzheimer’s Disease Neuroimaging Initiative

1 reference

16 April 2017

L Shen

6

0 references

Ronald C. Petersen

11

object named as

R C Petersen

1 reference

16 April 2017

13

C R Jack

1 reference

16 April 2017

10

P S Aisen

1 reference

16 April 2017

V K Ramanan

1

1 reference

16 April 2017

S L Risacher

2

1 reference

16 April 2017

K Nho

3

1 reference

16 April 2017

S Kim

4

1 reference

16 April 2017

S Swaminathan

5

1 reference

16 April 2017

T M Foroud

7

1 reference

16 April 2017

H Hakonarson

8

1 reference

16 April 2017

M J Huentelman

9

1 reference

16 April 2017

R C Green

12

1 reference

16 April 2017

R A Koeppe

14

1 reference

16 April 2017

W J Jagust

15

1 reference

16 April 2017

M W Weiner

16

1 reference

16 April 2017

A J Saykin

17

1 reference

16 April 2017

language of work or name

English

0 references

publication date

19 February 2013

1 reference

16 April 2017

1 reference

16 April 2017

19

1 reference

16 April 2017

351-357

1 reference

16 April 2017

3

1 reference

describes a project that uses

16 April 2017

genome-wide association study

1 reference

based on heuristic

inferred from title

cites work

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

The Alzheimer's disease neuroimaging initiative: progress report and future plans

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

PLINK: a tool set for whole-genome association and population-based linkage analyses

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Neuropathologic features of amnestic mild cognitive impairment

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Haploview: analysis and visualization of LD and haplotype maps

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Fast and accurate genotype imputation in genome-wide association studies through pre-phasing

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Estimation of the multiple testing burden for genomewide association studies of nearly all common variants

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Genome-wide transcription and the implications for genomic organization

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β

18 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Identification of common variants associated with human hippocampal and intracranial volumes

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Clinical practice. Mild cognitive impairment

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Alzheimer's disease: the challenge of the second century

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Endophenotype: a conceptual analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

The role of apolipoprotein E in Alzheimer's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Do cholinergic therapies have disease-modifying effects in Alzheimer's disease?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Treatment options in Alzheimer's disease: maximizing benefit, managing expectations

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Genome-wide association with diabetes-related traits in the Framingham Heart Study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Neuropathology of older persons without cognitive impairment from two community-based studies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Neurobiology of butyrylcholinesterase.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

From Alois to Amyvid: seeing Alzheimer disease.

3 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.19

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.19

Butyrylcholinesterase in the life cycle of amyloid plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.19

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.19

Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.19

The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.19

Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE epsilon 4, and hyperhomocysteinemia in neurodegenerative dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.19

Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.19

Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3661739

Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23419831

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.19

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MP.2013.19

1 reference

Dimensions Publication ID

1578673

1047993597

0 references

1578673

1 reference

1 reference

1 reference